Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. The revised … [+844 chars]Read More
Novo Nordisk hikes outlook on soaring demand for Wegovy Ozempic CNBC
